- Investing Ideas
- /
- Swiss High Return On Equity, Low Debt
Swiss High Return On Equity, Low Debt
UPDATED Sep 24, 2022
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
8 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVNNovartis | CHF74.36 | -4.1% | -3.4% | CHF162.3b | CHF90.79 | PE7.2x | E4.1% | 4.1% | Pharmaceuticals & Biotech | ||
| ABBNABB | CHF25.20 | -3.6% | -22.1% | CHF47.7b | CHF31.71 | PE11.2x | E8.9% | 3.2% | Capital Goods | ||
| GEBNGeberit | CHF412.90 | -4.0% | -42.9% | CHF14.3b | CHF500.59 | PE20.4x | E4.7% | 3.0% | Capital Goods | ||
| VACNVAT Group | CHF212.20 | -4.0% | -49.7% | CHF6.4b | CHF311.50 | PE23.7x | E5.9% | 2.6% | Capital Goods | ||
| LEHNLEM Holding | CHF1,520.00 | -0.8% | -32.3% | CHF1.7b | CHF1,826.67 | PE24.8x | E6.5% | 3.3% | Tech | ||
| IFCNINFICON Holding | CHF648.00 | -1.1% | -48.7% | CHF1.6b | CHF884.79 | PE19.2x | E7.0% | 3.2% | Tech | ||
| TXGNTX Group | CHF117.80 | -14.8% | -23.8% | CHF1.2b | CHF214.00 | PE1.6x | E-110.4% | 2.7% | Media | ||
| MOLNMolecular Partners | CHF6.04 | -6.4% | -66.4% | CHF217.5m | CHF19.39 | PE1.8x | E-68.7% | n/a | Pharmaceuticals & Biotech |
Page 1 of 1